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Abstract
Phospholipase D4 (PLD4) is a recently identified protein that is mainly expressed in the ionized calcium binding adapter
molecule 1 (Iba1)-positive microglia in the early postnatal mouse cerebellar white matter. Unlike PLD1 and PLD2, PLD4
exhibits no enzymatic activity for conversion of phosphatidylcholine into choline and phosphatidic acid, and its function is
completely unknown. In the present study, we examined the distribution of PLD4 in mouse cerebellar white matter during
development and under pathological conditions. Immunohistochemical analysis revealed that PLD4 expression was
associated with microglial activation under such two different circumstances. A primary cultured microglia and microglial
cell line (MG6) showed that PLD4 was mainly present in the nucleus, except the nucleolus, and expression of PLD4 was
upregulated by lipopolysaccharide (LPS) stimulation. In the analysis of phagocytosis of LPS-stimulated microglia, PLD4 was
co-localized with phagosomes that contained BioParticles. Inhibition of PLD4 expression using PLD4 specific small
interfering RNA (siRNA) in MG6 cells significantly reduced the ratio of phagocytotic cell numbers. These results suggest that
the increased PLD4 in the activation process is involved in phagocytosis of activated microglia in the developmental stages
and pathological conditions of white matter.
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Introduction
Phospholipase D4 (PLD4) is a member of the recently defined
non-classical PLD family, which is characterized by two conserved
HKD motifs (His-x-Lys-xxxx-Asp) in the C-terminal region [1]. In
mammals, three additional members, Sam-9 [2] [now designated
as PLD3 (MGI: 1333782)], PLD5 (MGI: 2442056), and
mitoPLD [3] [now designated as PLD6 (MGI: 2687283)] have
been identified in this family. HKD motifs are essential for PLD
enzymatic activity [4], however, unlike the classical types PLD1
and PLD2, non-classical PLDs exhibit no typical PLD enzymatic
activity for conversion of phosphatidylcholine into choline and
phosphatidic acid [2,5]. Furthermore, the members lack two
functional domains, phox homology (PX) and pleckstrin homology
(PH); both of which are found in the N-terminal regions of PLD1
and PLD2, and are involved in membrane targeting that leads
to membrane localization and activation of PLD [6,7,8,9,10].
Instead, the non-classical PLD family is composed of a short
N-terminal cytoplasmic tail, a transmembrane domain, and a
relatively long C-terminal region [1]. In PLD4, nine consensus
N-glycosylation sequences have been found in the C-terminal
region and the molecular weight has been shifted down by
deglycosylation, which suggests that this protein is a type II
membrane glycoprotein. Although classical PLD1 and PLD2
are known to be involved in a variety of cellular functions,
including intracellular transport, secretion, neuroprotection,
phagocytosis, and cellular adhesion [11,12,13,14,15], probably
by mediating phospholipid signaling, biological information of
these novel PLD family members is still limited.
The expression of PLD4 is strictly regulated in mouse brain
development. By RT-PCR analysis, PLD4 mRNA was first
detected in mouse cerebellum at postnatal day 0 (P0), increased
with age and peaked at P7, and then rapidly decreased to adult
levels by P21 [1]. A double labeling study of P7 mouse cerebellum
has shown that PLD4 mRNA is specifically present in ionized
calcium binding adapter molecule 1 (Iba1)-positive microglia. It
is well known that microglial activation occurs only for a short
time at this stage of cerebellar development [16], therefore, PLD4
expression might be associated with activation of these cells. In
addition to the brain, PLD4 mRNA has been detected in the
mesenchymal organs, including thymus, liver, and spleen by
GeneChip microarray analysis. In spite of its characteristic
expression patterns, no information about its function is available
to date.
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27544In the present study, we investigated the role of PLD4 in
microglia. We analyzed the distribution of PLD4 mRNA in mouse
cerebellar white matter, during development and under patholog-
ical conditions, to determine whether PLD4 expression was
associated with microglial activation. The function of PLD4 was
examined using a primary cultured microglia and microglial cell
line; both of which were derived from C57BL/6J mouse brain.
Our results demonstrated that PLD4 expression was closely
associated with microglial activation, and inhibition of its
expression by siRNA led to a significant decrease in phagocytotic
cells. This suggests that this protein is involved in phagocytosis of
microglia in the central nervous system (CNS) under physiological
and pathological conditions.
Materials and Methods
Animals
C57BL/6J mice were purchased from Japan SLC (Hamamatsu,
Japan) and sacrificed at postnatal day (P) 0, 3, 5, 7, 10 and 21. The
transgenic mouse line that contained two copies of mouse myelin
proteolipid protein (PLP) gene [17] was maintained in the Animal
Facility of the National Institute for Physiological Sciences.
Heterozygote (plp
tg/2) mice at 4.5 months of age and their wild
type littermates were used in this study. All animal experiments in
this study were conducted according to recommendations and
protocols approved by the Tokyo University of Pharmacy and Life
Sciences Animal Use Committee (#Y09-15).
Cells
For microglial culture, a mixed glial culture was prepared from
cerebral cortices of 1-day-old C57BL/6J mice according to the
method of Giulian and Baker (1986) [18]. After mechanical
and chemical dissociation, the cells were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM): nutrient mixture F12
(GIBCO/Invitrogen, Carlsbad, CA, USA) with 10% fetal bovine
serum (FBS) (GIBCO/Invitrogen) at 37uCi n5 %C O 2. Medium
was replaced every 4–5 days, and confluency was achieved after 14
days in vitro. Primary microglia were collected by gentle shaking by
hand to prevent activation.
MG6 cell line is a c-myc-immortalized cell line of mouse
microglia [19]. MG6 cells were maintained in 5% CO2 at 37uCi n
DMEM supplemented with 10% FBS, 10 mg/ml insulin (Sigma–
Aldrich, Saint Louis, MO, USA) and 0.1 mM 2-mercaptoethanol
(2-ME).
Enzyme-linked immunosorbent assay (ELISA)
To determine the microglial activation levels during lipopoly-
saccharide (LPS) stimulation, the amount of tumor necrosis factor
(TNF)-a in the culture medium was measured by mouse TNF-a
instant ELISA kit, according to the manufacturer’s instructions
(Bender Med Systems, Vienna, Austria).
Antibodies
The following antibodies were used for immunohistological and
immunocytochemical studies: rabbit polyclonal anti-Iba1 antibody
(1:400) (Wako, Osaka, Japan); rat monoclonal anti-myelin basic
protein (MBP) (1:100) antibody (Chemicon/Millipore, Billerica, MA,
USA); rabbit polyclonal anti-PLD4 C-terminal antibody (1:200),
which was produced by immunization with 16 amino acid residues
(from amino acid 488 to 503, YAMDLDRQVPSQDCVW) of PLD4
[1]; rat monoclonal anti-CD11b antibody (1:100) (AbD Serotec,
Kidlington, UK); biotinylated anti-rabbit and anti-rat IgG antibodies
(1:250) (Vector Laboratories, Burlingame, CA, USA); and Alexa 350-,
488- and 594-conjugated anti-rabbit and anti-rat IgG antibodies
(1:2000) (Molecular Probes, Invitrogen).
In situ hybridization
PLD4 cDNA (nucleotides 103–1613 corresponding to Genbank
NM_178911) was cloned in pcDNA3 vector and used to prepare
the probes. Digoxigenin-labeled antisense riboprobes were pre-
pared using DIG RNA labeling kit (Roche, Basel, Switzerland).
Paraffin sections of cerebella were prepared from P0–P21 C57BL/
6J mice. The sections (6 mm) were treated with proteinase K
(P0, 2 min; P3, 5 min; P5, 10 min; P7 and P10, 15 min; P21,
20 min), as described previously [20,21]. The sections were
hybridized with 2 mg/ml riboprobes at 60uC two overnight, and
color development was achieved by incubation with nitroblue
tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate (Roche).
Immunohistochemical analysis
The paraffin sections (6 mm) were boiled in citrate buffer
(pH 6.0) for 1 min in a microwave oven for heat-induced antigen
retrieval. The sections were incubated for 1 h in 0.01 M
phosphate-buffered saline (PBS) that contained 0.3% Triton X-
100 and 10% goat serum (PBS-TGS), and then overnight at 4uC
with primary antibodies diluted in PBS-TGS. After rinsing, the
sections were incubated with biotinylated secondary antibodies for
30 min at room temperature (RT). They were incubated with the
ABC reagent (1:50) (Vector Laboratories) for 30 min at RT, and
immunoreactions were visualized using 0.005% H2O2 in 3,39-
diaminobenzidine/50 mM Tris buffer for 10 min at RT. Images
were captured by light microscopy (Axio Scope Imaging System;
Carl Zeiss, Oberkochen, Germany). For quantification, the cells
were counted in three different regions (gray matter, proximal and
distal white matter). Distal white matter indicated subcortical
white matter. PLD4-positive cell numbers were obtained from six
individual sections from mice at each age. The areas were
measured by ImageGauge v4.23 (Fujifilm Tokyo Japan).
Immunocytochemical analysis
Primary microglia were collected by gentle shaking by hand,
and were transferred directly onto poly-L-lysine coated 13-mm
cover slips overnight. A total of 10
5 MG6 cells were grown on
13 mm cover slips overnight. The cells were treated with LPS
(500 ng/ml) or vehicle (PBS) for 24 h. The cells were fixed with
4% paraformaldehyde on ice for 30 min, and preincubated for 1 h
in PBS-TGS. The cells were incubated overnight at 4uC with
primary antibodies diluted in PBS-TGS. The cells were then
incubated with Alexa 350-, 488-, or 594-conjugated secondary
antibodies for 1 h at RT. Images were captured by confocal
microscopy (Olympus, Tokyo, Japan). Intensity of PLD4 signal per
mm
2 of each nucleus was measured by FV10-ASW v3.0
(Olympus).
Western blot analysis
The MG6 cells were plated at 2.5610
5 cells on a 100-mm Petri
dish. After cells became confluent, the plate was washed with PBS,
and homogenization buffer that contained 0.32 M sucrose, 5 mM
Tris–HCl, pH7.5, 0.75 mM aprotinin, 1 mM leupeptin, 1 mM
pepstatin, 0.4 mM phenylmethylsulfonyl fluoride (PMSF), and
1 mM dithiothreitol (DTT) was added. MG6 cells were harvested
by a cell scraper, and lysed by syringe with sequential passes
through 21 G, 23 G and 26 G needles. For nuclear fractionation,
hypotonic homogenization buffer that contained 0.5% Nonidet-
P40, 10 mM HEPES (pH 7.9), 10 mM KCl, 1.5 mM MgCl2,
0.75 mM aprotinin, 1 mM leupeptin, 1 mM pepstatin, 0.4 mM
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collected as the pellet by centrifugation of whole cell homogenate
at 8,000 rpm (MX-200; Tomy, Tokyo, Japan) for 15 min. The
protein concentration was determined by the bicinchoninic acid
method (Pierce/Thermo Scientific, Rockford, IL, USA). For
deglycosylation, the samples were incubated at 95uC for 5 min in
the presence of 0.5% sodium dodecyl sulfate (SDS) and 100 mM
2-ME, and cooled on ice for 3 min. Triton X-100 were added to a
final concentration of 2.5%, and incubated with 0.25 U/30 mg
protein of Peptide: N-glycosidase F (PNGase F) (Roche) for 16 h at
30uC.
Sample preparation, SDS-polyacrylamide gel electrophoresis
(PAGE), and immunoblot analysis were performed as previously
described [22]. MG6 cell homogenates were mixed with 26
sample buffer (0.25 M Tris–HCl, pH 6.8, 20% glycerol, 4% SDS,
0.2 M DTT, and bromophenol blue) and separated by SDS-
PAGE (10.5%, 768 cm, 1 mm thick). The proteins were
electrotransferred onto polyvinylidine difluoride membranes
(Amersham/GE Healthcare, Piscataway, NJ, USA) at 30 V for
16 h at 4uC. For immunoblot analysis, anti-PLD4 antibody (1:500)
and horseradish-peroxidase-conjugated anti-rabbit IgG antibody
(1:5000) were used. The bands were detected using ECL western
blot system (Amersham/GE Healthcare). For quantification, the
intensity of each band was measured by ImageGauge v4.23, and
the relative increase of PLD4 level induced by LPS stimulation was
calculated. Values were obtained from four experiments.
siRNA treatment
The commercially available double-stranded siRNA oligonu-
cleotide against PLD4 gene was purchased from Invitrogen. The
MG6 cells were transfected by 100 nM siRNA against PLD4 or
control siRNA (Invitrogen) for 48 h with the PrimaPort siRNA
transfection reagent (Credia-Japan, Kyoto, Japan), according to
the manufacturer’s protocol. The sequences of the double strand
PLD4-siRNA sets were as follows:
sense siRNA; 59-UGAUGUGGGAUGAGAAGUUCCGAGG-
39,
anti-sense siRNA; 59-CCUCGGAACUUCUCAUCCCACAUC-
A-39.
RT-PCR analysis
Total RNA was extracted from MG6 cells grown in six-well
tissue culture plates (7610
4 cells/well) by TRIzol Plus RNA
Purification Kit (Invitrogen). Isolated total RNA was then reverse
transcribed with TaKaRa RNA LA PCR
TM Kit (AMV) Ver.1.1
(Takara Bio Inc., Shiga, Japan). PLD4 and control glyceralde-
hyde-3-phoshate dehydrogenase (GAPDH) cDNAs were amplified
by the following specific primer sets:
PLD4 forward; 59-GGGGGTGTTCTACACTCCAA-39,
PLD4 reverse; 59-GCACATGCACCCTTATTG-39,
GAPDH forward: 59-AATGGTGAAGGTCGGTGTGAAC-39,
GAPDH reverse; 59-GAAGATGGTGATGGGCTTCC-39.
Phagocytosis assay
Primary microglia were transferred directly onto cover slips and
MG6 cells were plated at 10
5 cells/well in six-well tissue culture
plates that contained 1.5 ml DMEM/10% FBS. The cells were
treated with LPS (500 ng/ml) or vehicle for 24 h. For simple
phagocytosis assay, Alexa-594-conjugated Escherichia coli BioParti-
cles (Molecular Probes/Invitrogen) were added at a concentration
of 4610
6 BioParticles per well and left for 60 min. To determine
the types of endosomes, the cells were incubated with transferrin–
Alexa 594 (5 mg/ml) (Invitrogen) for 15 min or LysoTracker-
DNRed99 (1 mM) (Invitrogen) for 30 min at 37uC. After washing,
Alexa-488-conjugated E. coli BioParticles (Molecular Probes/
Invitrogen) were added. After rinsing, the cells were immuno-
stained by anti-PLD4 antibody as described. For quantification,
PLD4
+, PLD4
+/lysotracker
+, and PLD4
+/transferrin
+ vesicles per
cell were counted in 20 randomly selected cells from each sample.
Mean percentages of double-positive vesicles among total PLD4
+
vesicles per cell were calculated.
For siRNA treatment, MG6 cells were plated at 7610
4 cells/
well in six-well tissue culture plates. The cells were treated with
PLD4-siRNA (100 nM), control-siRNA (100 nM) or vehicle for
48 h by PrimaPort siRNA transfection reagent. After rinsing,
Alexa-488-conjugated E. coli BioParticles were added as described
above. After rinsing, phagocytotic MG6 cells were analyzed by
fluorescence-activated cell sorting (FACS) (Becton Dickinson).
Cell proliferation assay
MG6 cells were plated at 5,000 cells/well in a 96-well
microplate that contained 200 ml DMEM/10% FBS. They were
treated with PLD4-siRNA (100 nM), control-siRNA (100 nM) or
vehicle for 48 h. The following day, the cells were quantitated
using a CCK-8 cell counting kit (Dojindo Laboratories, Kuma-
moto, Japan). After 2 h incubation with the reagent, absorbance at
460 nm was determined using a microplate reader (Tecan,
Ma ¨nnedorf, Switzerland). The measured absorbance at 0 h after
adding LPS or PBS was used as a standard value.
Results
Localization change of PLD4 mRNA-positive cells in
developing mouse cerebellum
In our previous study, PLD4 mRNA was expressed in activated
microglia in 7-day-old cerebellar white matter [1]. In order to
examine the changes of distribution and numbers of PLD4-
mRNA-expressing cells during development, in situ hybridization
was performed with a specific probe for PLD4 mRNA in mouse
cerebella at various developmental stages (Fig. 1). PLD4-positive
signals were present only in a small number of cells inside of the
cerebellum at P0 (Fig. 1A, H). PLD4-positive cell number
increased in the proximal cerebellar white matter at P3 (Fig. 1B,
H) and they were distributed widely in the distal cerebellar white
matter at P5 and P7 (Fig. 1C, D, H). The signals became dispersed
to gray matter at P10 (Fig. 1E, H) and were rarely found at P21
(Fig. 1F, H). These distribution patterns were well correlated to
those of activated microglia in developing cerebellar white matter,
as described previously [23]. This suggested that PLD4 expression
was spatially and temporarily restricted during early postnatal
development in mouse cerebellum.
Increase of PLD4 expression in demyelinating lesions of
plp
tg/2 mice
Microglial activation occurs under various pathological condi-
tions in adult brain. In order to clarify whether expression of
PLD4 is induced in adult brains under pathological conditions that
activate microglia, we investigated the expression of PLD4 in
demyelinating lesions in the plp
tg/2 mice [17]. In this mutant,
normal myelin was formed during development. After 2 months of
age, degeneration of the CNS myelin becomes apparent although
it was initially accompanied by remyelination until 6 months of
age [17]. Sections of 4.5-month-old plp
tg/2 and wild type mouse
cerebella were immunostained with antibodies against Iba1
(Fig. 2A, D), MBP (Fig. 2B, E), and PLD4 (Fig. 2C, F). In the
plp
tg/2 mice, activated microglia showed intense signals of Iba1
and PLD4 (Fig. 2D, J and F, L) in the area where abnormal MBP
signals were observed (Fig. 2E, K). The intense signal patterns for
PLD4 in Microglial Phagocytosis
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tg/2 mice were not observed in wild
type littermates (Fig. 2A–C, G–I). The data indicated that PLD4
appeared in activated microglia in the demyelinating lesions of
adult brain.
Upregulation of PLD4 in the nuclei of activated microglia
by LPS stimulation
To determine the subcellular localization of PLD4 in microglia,
we used a primary microglia derived from cerebral cortices of 1-
day-old C57BL/6J mice. Primary microglia were cultured with or
without LPS for 24 h, and immunocytochemical analysis was
performed using anti-PLD4 and anti-CD11b antibodies. Only
weak PLD4-positive signals (green) were detected in nuclei
excluding the nucleolus of the vehicle-treated CD11b-positive
(red) microglia (Fig. 3A). In contrast, the signal intensities of PLD4
in the nucleus were much higher in LPS-stimulated cells compared
to those in the vehicle-treated cells (Fig. 3B, E). The nuclear
localization of PLD4 was also found in the MG6 microglial cell
line (Fig. 3C). PLD4-positive signal intensity was enhanced by
24 h LPS stimulation in MG6 cells (Fig. 3D, F). Dotted signals
scattered in the cytoplasm became prominent after LPS treatment.
PLD4 localization in phagosomes in phagocytic microglia
As shown in Fig. 2L (arrowheads), strong PLD4 signal was
observed in the cytoplasm of activated microglia in demyelinating
area. Activated microglia have phagocytic activity. Difference of
PLD4 localization between cultured cells and the cells in
demyelinating area may be due to difference of activation levels
Figure 1. Localization of PLD4-mRNA-expressing cells in developing mouse cerebellum. Distribution of PLD4-mRNA-positive cells was
examined by in situ hybridization in developing mouse cerebellum. PLD4-positive signals started to appear in the cerebellum at P0 (A). PLD4-positive
cells increased in the proximal cerebellar white matter at P3 (B), and were distributed widely in the distal cerebellar white matter at P5 (C) and P7 (D).
Signals started to be dispersed to the gray matter at P10 (Fig. 1E) and were rarely found at P21 (Fig. 1F). The morphology of cerebellar white matter
during development is illustrated (G). The red dotted squares indicate the approximate fields of view. Scale bar, 100 mm. PLD4-positive cell numbers
per area were obtained from six individual sections of mice at each age (H). The data were presented as mean 6 SE of six experiments.
doi:10.1371/journal.pone.0027544.g001
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primary microglial cells was examined during phagocytosis of
fluorescent BioParticles. After microglia were maintained with
(Fig. 4B) or without (Fig. 4A) LPS for 24 h, the cells were
incubated further with BioParticles for 1 h. PLD4-positive signals
(green) were found in BioParticle-containing phagosomes (yellow
in merged pictures in Fig. 4A, B). These data suggest the
involvement of PLD4 in phagocytosis.
To establish whether PLD4 was implicated in early or late
endosomes, primary microglial cells were labeled with transferrin
(early endosome marker) or lysotracker (late endosome maker),
and PLD4 localization was examined after phagocytosis of
BioParticles. Most PLD4-positive signals were found in transfer-
rin-containing phagosomes (Fig. 4C), whereas fewer signals were
overlapped with lysotracker-positive phagosomes (Fig. 4D). Also,
no PLD4-positive signals were observed in the plasma membrane.
The results suggest that PLD4 is predominantly present in early
phagosomes (Fig. 4I). The same results were obtained by the
experiments using MG6 cells (Fig. 4E, F, G, H and J). Thus,
upregulation and subcellular localization of PLD4 in activated
MG6 cells is identical to that in activated primary microglia.
Therefore, we used MG6 cells for further studies to establish a
functional role of PLD4.
Increase of PLD4 protein level by LPS stimulation in MG6
cells
Increased level of PLD4 was confirmed by western blot using
activated MG6 cells. After treatments of MG6 with LPS (500 ng/
ml) or vehicle for 24 h, the secretion levels of TNF-a in the culture
medium were 2,0696245 pg/ml in LPS-stimulated cells and
28610 pg/ml in vehicle-treated control cells, which indicated that
MG6 cells were activated. Western blot analysis of these cell
homogenates exhibited multiple PLD4-related bands of 70–
80 kDa (Fig. 5A). The multiple immunoreactive bands seemed
to contain different sizes of glycosylated moieties [1] and their
specificity was confirmed by antigen absorption test (data not
shown). A marked increase in PLD4 bands was found in LPS-
stimulated cells compared with controls (Fig. 5A). Thus, PLD4
expression was enhanced in LPS-activated MG6 cells.
The nuclear localization of PLD4 was also confirmed by
western blot analyses of the fractions prepared from MG6 cells
with or without LPS stimulation (Fig. 5B). Enrichment of
nucleoporin and elimination of GRP78/Bip (endoplasmic reticu-
lum fraction), COXIV (mitochondrial fraction) and GAPDH
(cytosolic fraction) demonstrated the purity of nuclear fractions
(data not shown). Spleen homogenate prepared from adult mice
was used as a positive control. Immunoblots exhibited ladder-like
Figure 2. Expression of Iba1, MBP and PLD4 in the cerebella of PLP
tg/2 and wild type mice. Sections prepared from 4.5-month-old PLP
tg/2
(D–F) and wild type (A–C) mouse cerebella were immunostained with antibodies against Iba1 (A, D), MBP (B, E), and PLD4 (C, F). In wild type, weak
signals of Iba1 (A) and PLD4 (B) were found in white matter. In contrast, the Iba1-positive (D) and PLD4-positive (F) strong signals were observed in
the proximal cerebellar white matter of PLP
tg/2 mice, where abnormal MBP-positive signals indicated demyelinated lesions (E). The enlarged images
of the squares in A–F are shown in G–L, respectively. The results indicate that PLD4 is upregulated in activated microglia in demyelinating conditions
in cerebellar white matter. Arrowheads in L show strong PLD4 signals in the cytoplasm. Scale bars; 100 mm in F for A–F and 20 mm in L for G–L.
doi:10.1371/journal.pone.0027544.g002
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possible sites in PLD4 molecule; therefore, PLD4 levels in
deglycosylated samples using PNGase F were compared. Two
PLD4-related bands were confirmed by absorption tests (data not
shown), and were detected in all the deglycosylated samples
(Fig. 5B). The predicted size of PLD4 peptide was approximately
48 kDa, which suggests that the lower band represented
completely deglycosylated PLD4. PLD4 was found in the nuclear
fraction and the supernatants, and the amounts significantly
increased in LPS-stimulated cells in all fractions (Fig. 5C).
Approximately twofold increase in PLD4 level was observed in
the nuclear fraction by LPS treatment.
Inhibition of phagocytosis by PLD4 siRNA
Involvement of PLD4 in phagocytosis was examined by
measuring phagocytotic activity under PLD4 knockdown condi-
tions using RNA interference (RNAi). First, we searched for an
appropriate RNAi condition, by which PLD4-siRNA showed the
highest efficiency of inhibition of PLD4 expression in the MG6
cells. MG6 cells were transfected by PLD4- or control-siRNA for
48 h and PLD4 mRNA expression levels were examined. RT-
PCR showed that MG6 cells silenced by 100 nM PLD4-siRNA
exhibited a significantly higher rate of inhibition compared with
cells treated by control-siRNA (Fig. 6A). Therefore, 100 nM of
each siRNA was used for further studies. No apparent effects of
PLD4 knockdown on TNF-a secretion were observed with and
without LPS (Fig. 6B). LPS treatment of MG6 cells stimulated
proliferation and the cell count increased about three times
compared with the absence of LPS stimulation (Fig. 6C). However,
the increase in cell numbers was significantly less when the cells
were treated with PLD4-siRNA (Fig. 6C), whereas it was not
significantly changed in cells that were not stimulated by LPS,
regardless of PLD4 knockdown. These results suggest that loss of
PLD4 did not affect microglial activation but inhibited the
increase in cell numbers induced by LPS stimulation. After siRNA
treatment followed by 1 h incubation with BioParticles, fluores-
cence-containing MG6 cells were counted by FACS. The ratio of
phagocytotic cell number in each siRNA-treated group was
compared with that in the control group (no siRNA) and the
percentage was calculated. As shown in Fig. 6D, phagocytic
activity in PLD4 siRNA-treated group (70.7864.73%) was
significantly decreased compared with that in control siRNA-
treated group (85.2165.48%, P,0.05). Taken together, these
results suggest that PLD4 is involved in phagocytic potency of
microglia-like MG6 cells.
Discussion
We demonstrated that one of the novel PLD family members
containing the transmembrane domain, PLD4, was expressed in
activated microglia found in developing cerebellum, as well as in
demyelinated white matter lesions. Primary cultured microglia and
the microglial cell line MG6 showed that PLD4 immuno-signals
were mainly present in the nucleus, apart from the nucleolus, and
were upregulated by LPS stimulation. PLD4 immunoreactivity
accumulated in phagosomes when BioParticles were added to
primary microglial cultures (Fig. 7). Inhibition of PLD4 expression
significantly reduced the number of phagocytotic cells. Together,
these results suggest that PLD4 is involved in phagocytosis of
activated microglia. The present study is believed to be the first to
demonstrate a role for one of the non-classical PLD family
members in cell functions.
PLD4 is upregulated in microglial activation by various
stimuli
Microglia are cells of myeloid origin that are distributed
diffusely throughout the brain. Microglia under normal conditions
monitor the status of the local surroundings, whereas under
pathological conditions, they migrate to the lesion, release a wide
range of soluble factors that include cytotoxins, neurotrophins and
immunomodulatory factors, and clear cellular debris by phagocy-
tosis [24]. Microglia are also activated temporally in developing
cerebellar white matter regions [16] where the projection of
climbing fibers change from multiple to mono-innervation of
Purkinje cells [25]. Under these conditions, microglia are
stimulated by various humoral factors, as well as by direct contact
of pathogens and cell debris. Gene expression patterns are
Figure 3. Nuclear localization of PLD4 in primary microglia and
MG6 cells. Primary microglial cells (A, B) and MG6 cells (C, D) were
treated with LPS (500 ng/ml) (B, D) or vehicle (A, C). (A and B) Primary
cultured microglia were identified by CD11b-positive signals (red). The
nuclei were weakly positive for PLD4 in vehicle-treated microglia (A),
whereas strong PLD4 signals were found in the nuclei of LPS-stimulated
microglia (B). (C and D) In MG6 cells, PLD4-positive signals (green) were
detected in the nucleus, except the nucleoli (C). The signal intensities of
PLD4 in the nuclei were markedly increased in LPS-stimulated MG6 cells
(D). The Z-stack image of the nucleus was obtained using confocal
microscopy. PLD4-positive signals (green) were detected in the internal
part of the nucleus (blue) in MG6 cells (D). Blue signals indicated DAPI-
stained nuclei. Scale bars, 20 mm. Intensity of nuclear PLD4 signals in
LPS-treated primary microglia (E) and MG6 cells (F) was calculated
against that of vehicle-treated controls. The data were presented as
mean 6 SE of four experiments. Asterisks in E and F indicate P,0.01
(Mann-Whitney’s U test).
doi:10.1371/journal.pone.0027544.g003
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stimulating factors is LPS. LPS binds to Toll-like receptors and
activates microglia by intracellular signaling pathways related to
nuclear factor-kB and microtubule-associated protein kinase [26].
Binding of antibodies to Fc receptors on the microglial surface
induces phagocytosis activity in microglia, which is associated
with inflammation [27]. In contrast, signals mediated by TREM2
(triggering receptor expressed on myeloid cells-2) and the pho-
sphatidylserine receptor are involved in microglial phagocytosis
without inflammation, for example, of apoptotic cells [24]. In
our in vitro and in vivo studies, PLD4 expression was upregulated
by LPS treatment, demyelination and normal developmental
processes. Thus, PLD4 function is probably associated with
microglial activation via a wide variety of cell stimuli.
Localization of PLD4 in microglia is dependent on their
activation levels
In the adult CNS, microglia thought to have at least three
clearly identifiable states, resting, reactive but non-phagocytic,
and phagocytic [28]. PLD4 changes its expression level and
its subcellular localization from the nucleus to phagosomes by
activation of microglia. This change between reactive and
phagocytic states is also observed in microglial cell lines, which
suggests that it is a feature of this protein in microglia. In
addition, accumulation of PLD4 in microglial cytoplasm in
demyelinated lesions (Fig. 2L) implies the involvement of these
microglial cells in phagocytic clearance, for example, removal of
damaged myelin. At present, several markers for activated
microglia are available, including Iba1 and CD11b. PLD4 is
also a good marker for the state of the microglia, because its
change of expression level and subcellular location are well
correlated with microglial activation.
The distribution was different from our previous study of
PLD4-transfected cells. When PLD4 is exogenously overex-
pressed in HEK293 or HeLa cells, the immunoreactivity is
mainly observed in the Golgi complex and endoplasmic reticulum
[1]. It is possible that only endogenous PLD4 protein can be
transported into the nucleus of microglia in culture. Based on the
nucleotide sequence (GenBank: NM_178911), PLD4 has a
transmembrane domain, and regular nuclear localization signals
are not found. Recent studies have demonstrated that certain
membrane proteins, including fibroblast growth factor receptor
[29], epidermal growth factor receptor [30–32] and ErbB-2 [33],
are transported into the nucleus by the nuclear transport system
mediated by importin b. Therefore, PLD4 might be transported
by similar mechanisms. RNAi showed partial inhibition of
proliferation during LPS stimulation, whereas the basic prolifer-
ation rate was not affected. This suggests its involvement in
proliferation, although it is still possible that a decrease in PLD4
affects microglial activation level, and in turn, influences
proliferation rate. Studies on PLD4 function in the nucleus are
in progress.
Classical and novel types of PLD family members are
involved in phagocytosis
The classical PLDs are involved in phagocytosis of macrophages
[34]. PLD1 is present in vesicles identified as the late endosomal/
lysosomal compartment, whereas PLD2 is localized at the plasma
membrane in macrophages [11,35,36]. In the phagocytic state of
Figure 5. Increase of PLD4 level by LPS stimulation in MG6
cells. MG6 cells were treated with LPS (500 ng/ml) or vehicle (PBS) for
24 hrs. (A) The Western blot analysis (15 mg proteins, 10.5% SDS-PAGE)
using anti-PLD4 antibody revealed that the levels of PLD4-related bands
(70–80 kDa) were increased in LPS-stimulated MG6 cells (left) compared
with those in control cells (right). (B) Whole cell homogenates (W),
nuclear fractions (N), and supernatants (C) were prepared. Mouse spleen
homogenate (S) was prepared as a positive control. Each sample was
deglycosylated by peptide-N-glycosidase F (PNGase F). Western blot
analysis (15 mg proteins, 10.5% SDS-PAGE) using PLD4 antibody
revealed that PLD4-positive bands were found in the nuclear fraction
and supernatants. After PNGase F treatment, PLD4-positive band sizes
were changed (48 kDa). (C) Intensity of each band was measured and
relative increase of PLD4 by LPS-stimulation in each fraction was
expressed graphically. The data are presented as mean 6 SE of four
experiments. Asterisk and double asterisk in C indicate P,0.01 and
P,0.05 by Mann-Whitney’s U test, respectively. Levels of PLD4 were
increased in all LPS-stimulated MG6 cell samples compared with those
in control cell samples.
doi:10.1371/journal.pone.0027544.g005
Figure 4. Localization of PLD4 in phagosomes of primary microglia and MG6 cells during phagocytosis. Primary cultured microglia (A,
B) and MG6 cells (E, F) were treated with LPS (500 ng/ml) (B, F) or vehicle (A, E) and were incubated with BioParticles (red). The cells were
immunostained with anti-PLD4 antibody (green). LPS treatment stimulated phagocytosis, and these cells contained more BioParticles (B, F). PLD4-
positive signals were co-localized with BioParticles in phagosomes (yellow in A, B, E, F), whereas they were mainly found in the nuclei of the cells
without BioParticles as shown in Fig. 3. LPS-stimulated primary cultured microglia (C, D) and MG6 cells (G, H) were incubated with BioParticles (green).
The cells were double labeled with anti-PLD4 antibody (blue) and Alexa 594-transferrin or Lysotracker-DNRed99 (red). PLD4- and transferrin-positive
signals were co-localized in BioParticle-containing phagosomes (white in C and G), whereas PLD4 and Lysotracker signals were co-localized only in a
few phagosomes (D and H). Scale bar in F (for E and F), 20 mm. Scale bar in D (for A to D) and H (for G and H), 10 mm. Percentages of PLD4
+/
Lysotracker
+ (Lysotracker) or PLD4
+/Transferrin
+ (transferrin) vesicles were compared in primary microglia (I) and in MG6 cells (J). The data were
presented as mean 6 SE of four experiments. Asterisks in I and J indicate P,0.01 (Mann-Whitney’s U test).
doi:10.1371/journal.pone.0027544.g004
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PLoS ONE | www.plosone.org 8 November 2011 | Volume 6 | Issue 11 | e27544Figure 6. Influence of PLD4 knock down in MG6 cells by siRNA treatment. (A) MG6 cells were transfected with PLD4-siRNA or control (cont)-
siRNA (100 nM each) for 48 h. Total RNA was isolated from these cells and analyzed by RT-PCR for PLD4 (above) and GAPDH (below) mRNA
expression. Expression of PLD4 mRNA was efficiently reduced by 100 nM PLD4 siRNA treatment. The immunofluorescence staining of PLD4 (green)
revealed that PLD4 was downregulated in PLD4-siRNA-treated cells (left), compared with Cont-siRNA (right) by 100 nM siRNA treatment. Scale bars,
20 mm. (B) MG6 cells were transfected with siRNA for 24 h, and LPS (500 ng/ml) or PBS (vehicle) were added to the medium. After 24 h, secretion of
TNF-a was measured by ELISA. Measurement of PLD4-siRNA-treated cells was used as a standard value. Secretion of TNF-a was not significant in the
siRNA-treated groups (n=4). (C) LPS-stimulated (dark gray bars) or vehicle-treated (gray bars) MG6 cells were treated with or without siRNA for 48 h.
Measurement at 0 h before addition of LPS or PBS was used as a standard value. Proliferation was examined by cell counting kit (n=4). (D) MG6 cells
were transfected with PLD4- or control (cont)-siRNA for 48 h. Vehicle-treated cells were used as a control. Cells were incubated with BioParticles.
BioParticle-containing cells were analyzed by FACS, and phagocytic activity was calculated by dividing these cell numbers by the total. The graph
shows the percentage of phagocytic activity of each siRNA-treated cells compared with that of the control cells. The data are presented as mean 6 SE
of five experiments. Asterisks in C and double asterisk in D indicate P,0.01 and P,0.05 by Mann-Whitney’s U test, respectively.
doi:10.1371/journal.pone.0027544.g006
Figure 7. Localization change of PLD4 in cultured microglia. PLD4 was located in the nucleus during the resting state. After LPS stimulation,
expression of PLD4 was increased. In the phagocytotic state eating BioParticles, PLD4 accumulated in the early phagosomes.
doi:10.1371/journal.pone.0027544.g007
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internalized phagosomes, whereas PLD2 is only observed in
nascent phagosomes. Double knockdown studies using specific
siRNA against PLD1 and PLD2 have exhibited a decrease in the
phagocytic rates to approximately 70% [11]. Thus, the classical
PLD members play important roles in distinct processes of
phagocytosis, probably through local production of phosphatidic
acid. In contrast to the classical PLD family, PLD4 showed no
enzymatic activity for hydrolysis of phosphatidylcholine to choline
and phosphatidic acid [1]. Furthermore, a relatively long C-
terminal tail with sugar moieties of PLD4 is probably located
inside the phagosomes; therefore, the topology of the protein is
different from that of classical PLDs. PLD4 is also expressed in the
reticuloendothelial system [1]; therefore, understanding the
mechanism of this protein could give us fundamental information
about phagocytotic processes.
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